Literature DB >> 12654760

Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole.

Agostinho Cruz1, M Isaura Sousa, Zaida Azeredo, Emilia Leite, J C Figueiredo de Sousa, Miguel Cabral.   

Abstract

From 53 samples of human faeces containing Giardia lamblia cysts, 18 isolates were successfully excysted in vitro, and cultivated axenically in TYI-S-33 modified medium. The in vitro effects of metronidazole and albendazole on these isolates were evaluated by the trophozoite adherence inhibition method. The IC50 was between 2.4 and 11.5 micro M for metronidazole and 0.027 and 0.192 micro M for albendazole. These IC50 values were similar to those found for the ATCC 30888 and 30957 reference isolates. All isolates were susceptible to the antiparasitic drugs tested. These results suggest that resistance of G. lamblia to metronidazole and albendazole does not seem to be a significant problem in our population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654760     DOI: 10.1093/jac/dkg150

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.

Authors:  Noa Tejman-Yarden; Maya Millman; Tineke Lauwaet; Barbara J Davids; Frances D Gillin; Linda Dunn; Jacqueline A Upcroft; Yukiko Miyamoto; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

2.  Evaluation of Giardia duodenalis viability after metronidazole treatment by flow cytometry.

Authors:  Joana Barbosa; Acácio Gonçalves Rodrigues; Maria José Pérez; Cidália Pina-Vaz
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-11-21       Impact factor: 2.743

3.  Giardia lamblia: a report of drug effects under cell differentiation.

Authors:  Moema A Hausen; Richard Pereira de Oliveira; Ana Paula Rocha Gadelha; Loraine Campanati; Jorge José de Carvalho; Laís de Carvalho; Helene Santos Barbosa
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

4.  Albendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical study.

Authors:  Oguz Karabay; Ali Tamer; Huseyin Gunduz; Derya Kayas; Huseyin Arinc; Harika Celebi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

5.  A novel in vitro image-based assay identifies new drug leads for giardiasis.

Authors:  Christopher J S Hart; Taylah Munro; Katherine T Andrews; John H Ryan; Andrew G Riches; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-01-27       Impact factor: 4.077

6.  Genetic variation in metronidazole metabolism and oxidative stress pathways in clinical Giardia lamblia assemblage A and B isolates.

Authors:  Christina S Saghaug; Christian Klotz; Juha P Kallio; Hans-Richard Brattbakk; Tomasz Stokowy; Toni Aebischer; Inari Kursula; Nina Langeland; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2019-05-10       Impact factor: 4.003

7.  High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro.

Authors:  Juliane Hahn; Frank Seeber; Herbert Kolodziej; Ralf Ignatius; Michael Laue; Toni Aebischer; Christian Klotz
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

8.  An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery.

Authors:  Snigdha Tiash; Jake Saunders; Christopher J S Hart; John H Ryan; Andrew G Riches; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-03-13       Impact factor: 4.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.